Clinical Trial: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193511) titled 'Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors' on Sept. 24.

Brief Summary: This study, the first clinical trial of AVZO-103, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of AVZO-103 when administered intravenously as a monotherapy and in combination therapy to patients with locally advanced or metastatic urothelial cancer or other solid tumors.

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Solid Tumor Cancer Locally Advance...